FUT4 and myocardial infarction: Until now, hPSC-derived CPCs (SSEA1+ cells) were used in rodents after myocardial infarction (MI)8, non-human primates models9,10 and human clinical trials11, which suggests that they may be promising sources for cardiac regenerative medicine.